As IGFBPs are proving to be better therapeutic potential in metabolic disorders as compared to IGF, studies in this direction will help to define both diagnostic and therapeutic roles for IGFBPs in T1D and its complications. The gene discussed is IGF1; the disease is type 1 diabetes mellitus.